ZSVC

  • Lianchuan Bio closes RMB115m Series B round

    Lianchuan Bio recently announced the completion of a total of 115 million yuan in a Series B financing round.
    This round of financing was led by Hangzhou Heda Bio-Pharmaceutical Venture Partnership, with participation from Beijing Junchuan Capital, Hangzhou Taimeng Investment, as well as existing investors Sinowisdom, ZSVC and Crestvalue.